MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants

A preliminary prospective study

Cinzia Auriti, Giusi Prencipe, Barbara Caravale, Maria Franca Coletti, Maria Paola Ronchetti, Fiammetta Piersigilli, Chiara Azzari, Vincenzo M. Di Ciommo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background:As described in animal models, the lectin-complement pathway is central to the propagation of ischemia-reperfusion injuries in many tissues, including the brain. Similarly, it might affect the genesis of brain damage in preterm infants. MBL2 gene single-nucleotide polymorphisms (SNPs), regulating mannose-binding lectin (MBL) serum levels, could predict the risk of adverse neurological outcome in these infants.

Methods:To evaluate the association between SNPs of the MBL2 gene and long-term neurological outcomes in preterm infants, 75 infants (gestational age (GA) ≤ 32 wk) were observed in a prospective longitudinal study and assessed by clinical and instrumental exams at 12 and 24 mo of corrected age (CA). They were genotyped for the promoter polymorphism -221 and for the exon-1 variant alleles (at codons 52, 54, and 57) of the MBL2 gene.

Results:The MBL2 exon-1 OO genotype was more frequent in children with an adverse neurological outcome (5/35; 7%) than in controls (0/40; 0%), P = 0.045. The risk of intraventricular hemorrhage in carriers of the genotype OO was marked, without reaching statistical significance (odds ratio: 8.67; 95% confidence interval: 0.87-86.06; P = 0.07).

Conclusion:Preterm infants who are carriers of MBL2 exon-1 OO genotype are exposed to an increased risk of adverse neurological outcomes.

Original languageEnglish
Pages (from-to)464-469
Number of pages6
JournalPediatric Research
Volume76
Issue number5
DOIs
Publication statusPublished - Nov 5 2014

Fingerprint

Premature Infants
Exons
Genotype
Prospective Studies
Single Nucleotide Polymorphism
Mannose-Binding Lectin Complement Pathway
Genes
Mannose-Binding Lectin
Brain
Reperfusion Injury
Lectins
Codon
Gestational Age
Longitudinal Studies
Animal Models
Alleles
Odds Ratio
Confidence Intervals
Hemorrhage
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants : A preliminary prospective study. / Auriti, Cinzia; Prencipe, Giusi; Caravale, Barbara; Coletti, Maria Franca; Ronchetti, Maria Paola; Piersigilli, Fiammetta; Azzari, Chiara; Di Ciommo, Vincenzo M.

In: Pediatric Research, Vol. 76, No. 5, 05.11.2014, p. 464-469.

Research output: Contribution to journalArticle

Auriti, Cinzia ; Prencipe, Giusi ; Caravale, Barbara ; Coletti, Maria Franca ; Ronchetti, Maria Paola ; Piersigilli, Fiammetta ; Azzari, Chiara ; Di Ciommo, Vincenzo M. / MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants : A preliminary prospective study. In: Pediatric Research. 2014 ; Vol. 76, No. 5. pp. 464-469.
@article{2b5675e2562d45be9c6d2ef21b52be15,
title = "MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants: A preliminary prospective study",
abstract = "Background:As described in animal models, the lectin-complement pathway is central to the propagation of ischemia-reperfusion injuries in many tissues, including the brain. Similarly, it might affect the genesis of brain damage in preterm infants. MBL2 gene single-nucleotide polymorphisms (SNPs), regulating mannose-binding lectin (MBL) serum levels, could predict the risk of adverse neurological outcome in these infants.Methods:To evaluate the association between SNPs of the MBL2 gene and long-term neurological outcomes in preterm infants, 75 infants (gestational age (GA) ≤ 32 wk) were observed in a prospective longitudinal study and assessed by clinical and instrumental exams at 12 and 24 mo of corrected age (CA). They were genotyped for the promoter polymorphism -221 and for the exon-1 variant alleles (at codons 52, 54, and 57) of the MBL2 gene.Results:The MBL2 exon-1 OO genotype was more frequent in children with an adverse neurological outcome (5/35; 7{\%}) than in controls (0/40; 0{\%}), P = 0.045. The risk of intraventricular hemorrhage in carriers of the genotype OO was marked, without reaching statistical significance (odds ratio: 8.67; 95{\%} confidence interval: 0.87-86.06; P = 0.07).Conclusion:Preterm infants who are carriers of MBL2 exon-1 OO genotype are exposed to an increased risk of adverse neurological outcomes.",
author = "Cinzia Auriti and Giusi Prencipe and Barbara Caravale and Coletti, {Maria Franca} and Ronchetti, {Maria Paola} and Fiammetta Piersigilli and Chiara Azzari and {Di Ciommo}, {Vincenzo M.}",
year = "2014",
month = "11",
day = "5",
doi = "10.1038/pr.2014.118",
language = "English",
volume = "76",
pages = "464--469",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants

T2 - A preliminary prospective study

AU - Auriti, Cinzia

AU - Prencipe, Giusi

AU - Caravale, Barbara

AU - Coletti, Maria Franca

AU - Ronchetti, Maria Paola

AU - Piersigilli, Fiammetta

AU - Azzari, Chiara

AU - Di Ciommo, Vincenzo M.

PY - 2014/11/5

Y1 - 2014/11/5

N2 - Background:As described in animal models, the lectin-complement pathway is central to the propagation of ischemia-reperfusion injuries in many tissues, including the brain. Similarly, it might affect the genesis of brain damage in preterm infants. MBL2 gene single-nucleotide polymorphisms (SNPs), regulating mannose-binding lectin (MBL) serum levels, could predict the risk of adverse neurological outcome in these infants.Methods:To evaluate the association between SNPs of the MBL2 gene and long-term neurological outcomes in preterm infants, 75 infants (gestational age (GA) ≤ 32 wk) were observed in a prospective longitudinal study and assessed by clinical and instrumental exams at 12 and 24 mo of corrected age (CA). They were genotyped for the promoter polymorphism -221 and for the exon-1 variant alleles (at codons 52, 54, and 57) of the MBL2 gene.Results:The MBL2 exon-1 OO genotype was more frequent in children with an adverse neurological outcome (5/35; 7%) than in controls (0/40; 0%), P = 0.045. The risk of intraventricular hemorrhage in carriers of the genotype OO was marked, without reaching statistical significance (odds ratio: 8.67; 95% confidence interval: 0.87-86.06; P = 0.07).Conclusion:Preterm infants who are carriers of MBL2 exon-1 OO genotype are exposed to an increased risk of adverse neurological outcomes.

AB - Background:As described in animal models, the lectin-complement pathway is central to the propagation of ischemia-reperfusion injuries in many tissues, including the brain. Similarly, it might affect the genesis of brain damage in preterm infants. MBL2 gene single-nucleotide polymorphisms (SNPs), regulating mannose-binding lectin (MBL) serum levels, could predict the risk of adverse neurological outcome in these infants.Methods:To evaluate the association between SNPs of the MBL2 gene and long-term neurological outcomes in preterm infants, 75 infants (gestational age (GA) ≤ 32 wk) were observed in a prospective longitudinal study and assessed by clinical and instrumental exams at 12 and 24 mo of corrected age (CA). They were genotyped for the promoter polymorphism -221 and for the exon-1 variant alleles (at codons 52, 54, and 57) of the MBL2 gene.Results:The MBL2 exon-1 OO genotype was more frequent in children with an adverse neurological outcome (5/35; 7%) than in controls (0/40; 0%), P = 0.045. The risk of intraventricular hemorrhage in carriers of the genotype OO was marked, without reaching statistical significance (odds ratio: 8.67; 95% confidence interval: 0.87-86.06; P = 0.07).Conclusion:Preterm infants who are carriers of MBL2 exon-1 OO genotype are exposed to an increased risk of adverse neurological outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84908576731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908576731&partnerID=8YFLogxK

U2 - 10.1038/pr.2014.118

DO - 10.1038/pr.2014.118

M3 - Article

VL - 76

SP - 464

EP - 469

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -